You have 9 free searches left this month | for more free features.

City

Beijing (1)

Condition

B Cell Lymphoma (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Shanghai Hengrui Pharmaceutical Co., Ltd. (1)

Collaborator

Intervention

shr-a1912 (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

shr-a1912

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

B Cell Lymphoma Trial in Beijing (SHR-A1912)

Recruiting

B Cell Lymphoma

SHR-A1912

Beijing, Beijing, China

Beijing Cancer Hospital

Apr 15, 2022